K33 Report: Fund Rate Indicator Suggests Crypto Market to Bottom Out and Rebound in the Next Few Weeks
According to CoinDesk, cryptocurrency research firm K33 Research stated in a market report released on Tuesday that although investors are still concerned about the risk of further decline, there is a reliable indicator that suggests a significant rebound in the market in the coming weeks and months.
According to the report, the 30 day average funding rate for Bitcoin (BTC) perpetual contracts has dropped to negative levels, a situation that has only occurred six times since 2018. K33 analysts Vetle Lunde and David Zimmerman wrote:
In the past, when monthly funding rates hit negative levels, it coincided with the market bottoming out
The report points out that based on the previous situation where the indicator flipped to a negative value, Bitcoin's average return rate in the following 90 days was 79%, and the median return rate in 90 days was 55%.
Meanwhile, due to the influx of short positions, the open interest in derivative contracts gradually climbed to the highest level since late July. The report points out that, combined with sustained negative funding rates, these indicators indicate potential short selling risks in the market. The analyst wrote:
The similar funding rate environment provides very strong reasons for active exposure to BTC in the coming months
(责任编辑:要闻)
-
但是现在,我离开了,是好是坏,谁知道呢!但总能够不能停吧,我又重新站在了十字路口,总得向前。...[详细]
-
但截止发稿前,还有642家公司等待审批——窗口期能持续多久,没有人能给出预测,大家都在急不可耐地往前冲。...[详细]
-
那什么样的人适合做运营?在我这个段位,我还不知道。...[详细]
-
特别在医院实力的介绍和治疗技术都要精准到位。...[详细]
-
3、AD-3虽然点击量很低,但依然带来了转化,说明这个位置隐蔽,但是商品是用户所需要的。...[详细]
-
显然看清自己比什么都重要,当然,定位不是一种好高骛远,不切实际的定位,要站在行业的高度去做,或者比肩行业的领军人物作为标榜,毕竟站在金字塔顶端的寥寥无几,而在细分领域,则有无数个小山头让企业去选择,一...[详细]
-
WalletConnect 通过 WCT 空投正式登陆 Solana,开启多链扩展新篇章
今日头条也好、UC头条号也好,一点资讯也好、你们看到的、吐槽的那些的水文或者垃圾稿,那些标题党和耸人听闻的文章,90%以上是由这些“职业做号人”生产的。...[详细]
-
第一个硬性门槛,就是达到“连续三年盈利”——大部分公司对这个门槛无法僭越。...[详细]
-
唐纳德·特朗普接待了 220 名顶级特朗普表情包持有者,但并非没有争议:以下是您需要了解的信息
良好的课堂可是很快让孩子融入到集体中,师生互动就必不可少。...[详细]
-
以5000元的保额为例,“这是我们通过大数据分析、人物画像,与对整个人群的分析后,得出一年用于门诊报销的用药量,差不多在3000-5000块钱之间。...[详细]